Jonathan MilnerMember of the Advisory Panel
Dr Jonathan Milner, co-founder and currently Deputy Chairman of Abcam plc, is an experienced entrepreneur and investor and is passionate about supporting UK healthcare and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three technology companies to IPO on AIM.
Dr Milner gained his doctorate in Molecular Genetics at Leicester University after graduating in Applied Biology at Bath. From 1992–95, he was a post-doctoral researcher at Bath, following which he worked at the University of Cambridge in the laboratory of Professor Tony Kouzarides researching the molecular basis of breast cancer. He identified the market opportunity for supplying high-quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides.
Dr Milner is currently Chairman of Axol Bioscience, Cambridge Allergy Therapy Limited and PhoreMost Limited and a non-executive director of Horizon Discovery, Frontier Developments, Syndicate Room Limited and GeoSpock Limited. He also sits on the advisory boards of Desktop Genetics Ltd, Repositive Ltd, HealX Limited and Definigen Ltd.